Elevated serum CA-125 levels in a patient with nephrotic syndrome

American Journal of Case Reports

Volumn 9, Issue , 2008, Pages 351-354

  Orlowska Kowalik, Grazyna ^a   Malecka Massalska, Teresa ^a   Ksiazek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amyloid; CA 125; Neoplastic disease; Nephrotic syndrome; Ovarian tumor

Indexed keywords

CA 125 ANTIGEN; CYCLOPHOSPHAMIDE; TUMOR MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DIURESIS; DOPPLER FLOWMETRY; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LABORATORY TEST; NEPHROTIC SYNDROME; OVARIECTOMY; OVARY CYST; OVARY DISEASE; PERITONEAL DIALYSIS; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PROTEINURIA; RADIOIMMUNOASSAY; SALPINGITIS; SYMPTOMATOLOGY; TRANSVAGINAL ECHOGRAPHY; URINALYSIS;

EID: 78249250007     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Greenberg E, Divertie MB, Woolner LB: A review of unusual systemic manifestations associated with carcinoma. Amer J Med, 1964; 36: 106-20.
2. Lee JC, Yamauchi H, Hopper J: The association of cancer and the nephrotic syndrome. Ann Intern Med, 1966; 64: 44-51.
3. Kim YT, Rha S, Shim Ch: A case of paraneoplastic nephrotic syndrome in patient with ovarian carcinoma. Yonsei Medical J, 2003; 44: 539-43.
4. Forgy AP, Ewing TL, Flaningam J: Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration. Gynecol Oncol, 2001; 80: 96-98.
5. Calls J, Cases A, Filella X: Increased serum levels of CA-125 in patients with nephrotic syndrome. [in Spanish] Nefrologia, 1993; 13: 127-30.
6. Beauvais P, Vaudour G, Boccon Gibod L: Membranous nephropathy associated with ovarian tumor in young girl: recovery after removal. Eur J Pediatr, 1989; 148: 624-25.
7. Bergman JR, Bidart JM, George M: Elevation of CA-125 in patients with benign and malignant ascites. Cancer, 1987; 59: 213-17.
8. Hoyt RE, Hamilton JF: Ovarian cancer associated with the nephrotic syndrome. Obstet Gynecol, 1989; 70: 513-14.
9. Zuckerman E, Lanir A, Sabp E: Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterology, 1999; 94: 1613-18.
10. Sevinc A, Buyukberber S, Sari R: Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites. Anticancer Res, 2000; 20(2B): 1201-3.
11. Sevinc A, Buyukberber S, Sari R: Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids. Gynecol Oncol, 2000; 77: 254-57.
12. Sevinc A, Buyukberber S, Sari R: Elevated serum CA-125 levels: Hepatitis or ascites? Gynecol Oncol, 1999; 76: 141.
13. Collazos J, Genolla J, Ruibal A: CA-125 levels in patients with non-neoplastic liver disease. A clinical and laboratory study. Scan J Clin Lab Invest, 1992; 52: 201-6.
14. Kabawat SE, Bast RC, Bhan AK: Tissue distribution of a coelomic epithelium-related antigen recognised by the monoclonal antibody OC 125. Int J Gynecol Pathol, 1984; 2: 275-85.
15. Mezger J, Lamerz R, Amholdt H: Tumor marker in der diagnostic von aszites und pleura punktaten. Onkologie, 1986; 9: 1147-52.
16. Sari R, Yildirim B, Sevinc A: Re. Zuckerman et al.-Sensitivity of CA-125 in patients with liver cirrhosis in the presence of ascites. Am J Gastroenterol, 2001; 96(1): 253-54.